Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 3.23 USD 4.19% Market Closed
Market Cap: 33.1m USD

Intrinsic Value

The intrinsic value of one BNR stock under the Base Case scenario is 15.16 USD. Compared to the current market price of 3.23 USD, Burning Rock Biotech Ltd is Undervalued by 79%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BNR Intrinsic Value
15.16 USD
Undervaluation 79%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Burning Rock Biotech Ltd

Valuation History Unavailable

Historical valuation for BNR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Burning Rock Biotech Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Burning Rock Biotech Ltd

Current Assets 776.6m
Cash & Short-Term Investments 519.8m
Receivables 165.9m
Other Current Assets 90.9m
Non-Current Assets 108.7m
PP&E 100.3m
Intangibles 421k
Other Non-Current Assets 7.9m
Efficiency

Free Cash Flow Analysis
Burning Rock Biotech Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Burning Rock Biotech Ltd

Revenue
515.8m CNY
Cost of Revenue
-153.4m CNY
Gross Profit
362.4m CNY
Operating Expenses
-684.8m CNY
Operating Income
-322.4m CNY
Other Expenses
-24.2m CNY
Net Income
-346.6m CNY
Fundamental Scores

BNR Profitability Score
Profitability Due Diligence

Burning Rock Biotech Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROIC is Increasing
Positive 3-Years Revenue Growth
Negative 1-Year Revenue Growth
25/100
Profitability
Score

Burning Rock Biotech Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

BNR Solvency Score
Solvency Due Diligence

Burning Rock Biotech Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
55/100
Solvency
Score

Burning Rock Biotech Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BNR Price Targets Summary
Burning Rock Biotech Ltd

There are no price targets for BNR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Burning Rock Biotech Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for BNR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one BNR stock?

The intrinsic value of one BNR stock under the Base Case scenario is 15.16 USD.

Is BNR stock undervalued or overvalued?

Compared to the current market price of 3.23 USD, Burning Rock Biotech Ltd is Undervalued by 79%.

Back to Top